Multimorbidity Treatment Burden Questionnaire (MTBQ): Translation, Cultural Adaptation, and Validation in French-Canadian.
Can J Aging
; : 1-9, 2022 May 10.
Article
in English
| MEDLINE | ID: covidwho-2261454
ABSTRACT
Reliable treatment burden measures are needed given the aging population and the associated increase in multimorbidity and polypharmacy. Treatment burden is defined as the effort to care for one's health and the resulting impact on one's daily life. This study aimed to translate the Multimorbidity Treatment Burden Questionnaire (MTBQ) for French-Canadians and assess its reliability and validity. The MTBQ was translated and tested with cognitive debriefing interviews, and the French version (MTBQ-F) was then administered 2 times among 105 participants. Reliability and validity were examined using the intra-class correlation coefficient (ICC), Cronbach's alpha, and Spearman's correlations. The median global MTBQ-F scores were 32.69 (interquartile range [IQR] 21.15-48.08) and 30.77 (IQR 21.15-46.15) for the first and second administrations, respectively. Test-retest (ICC 0.73; 95% CI 0.63-0.81) and internal consistency reliability (Cronbach's alpha 0.80) were good. There was a moderate positive correlation between the MTBQ-F score and the number of self-reported conditions (rho 0.28). This valid instrument could identify patients experiencing a high treatment burden and assess the impact of interventions among them.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Observational study
/
Prognostic study
Language:
English
Journal:
Can J Aging
Journal subject:
Geriatrics
Year:
2022
Document Type:
Article
Affiliation country:
S0714980822000058
Similar
MEDLINE
...
LILACS
LIS